Literature DB >> 3310241

Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents.

A J Murgo1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3310241

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  19 in total

Review 1.  Drug-induced thrombotic microangiopathy: incidence, prevention and management.

Authors:  R Pisoni; P Ruggenenti; G Remuzzi
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  [Thrombotic microangiopathy after extracorporeal circulation: important differential diagnosis].

Authors:  T Schmidt; D A Tsakiris; M Grapow; M Siegemund
Journal:  Anaesthesist       Date:  2010-12-25       Impact factor: 1.041

3.  Thrombotic thrombocytopenic purpura and bone marrow necrosis associated with disseminated gastric cancer.

Authors:  Zaher K Otrock; Ali T Taher; Jawad A Makarem; Mireille M Kattar; Ghazi Nsouli; Ali I Shamseddine
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

Review 4.  Pathogenesis of the hemolytic uremic syndromes: current concepts.

Authors:  B S Kaplan; V V Vedaranayanan
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

5.  Common emergencies in cancer medicine: infectious and treatment-related syndromes, Part II.

Authors:  C R Thomas; K J Stelzer; J G Douglas; W J Koh; L V Wood; R Panicker
Journal:  J Natl Med Assoc       Date:  1994-11       Impact factor: 1.798

Review 6.  Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes.

Authors:  B S Kaplan; T G Cleary; T G Obrig
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

Review 7.  Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS): the new thinking.

Authors:  J Liu; M Hutzler; C Li; L Pechet
Journal:  J Thromb Thrombolysis       Date:  2001-05       Impact factor: 2.300

8.  Haemolytic uraemic syndrome associated with gemcitabine.

Authors:  Irene Moya-Horno; Rosa Querol Niñerola; Teresa Bonfill Abella; Elsa Dalmau Pórtulas; Enrique Gallardo-Díaz; Eugeni Saigí Grau; Carles Pericay Pijaume
Journal:  Clin Transl Oncol       Date:  2010-05       Impact factor: 3.405

Review 9.  Recurrent thrombotic thrombocytopenic purpura (TTP) as a complication of acute relapsing pancreatitis.

Authors:  Jayant A Talwalkar; Frederick W Ruymann; Paul Marcoux; Francis A Farraye
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

10.  Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma.

Authors:  Nishant Kalra; Rahul Kad; Sayed Osama
Journal:  Int J Clin Oncol       Date:  2007-10-22       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.